Log In
Print
BCIQ
Print
Print this Print this
 

Leukotac, inolimomab

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionAnti-CD25 mAb
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat steroid-refractory acute graft-versus-host disease (GvHD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today